Isothiazolo-pyrimidinedione derivatives as TRPA1 modulators

Details for Australian Patent Application No. 2010227224 (hide)

Owner Glenmark Pharmaceuticals, S.A.

Inventors Kumar, Sukeerthi; Thomas, Abraham; Margal, Sanjay; Khairatkar-Joshi, Neelima; Mukhopadhyay, Indranil

Agent Freehills

Pub. Number AU-A-2010227224

PCT Pub. Number WO2010/109328

Priority 61/171,355 21.04.09 US; 665/MUM/2009 23.03.09 IN

Filing date 22 March 2010

Wipo publication date 30 September 2010

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

29 September 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Sep 2011

29 September 2011 PCT application entered the National Phase

  PCT publication WO2010/109328 Priority application(s): WO2010/109328

27 October 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 22 Sep 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010227225-Furopyrimidinedione derivatives as TRPA1 modulators

2010227221-Combinations including pneumococcal serotype 14 saccharide